くすりのしおり

Injection
Published: 4/2017

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
IA-call 100mg
 Active ingredient:
Cisplatin
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine inhibits DNA synthesis of cancer cells to suppress proliferation of cancer cells and reduce the tumor size.
It is usually used to treat hepatocellular cancer.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itching, rash, etc.) to any medicines.
    If you have renal disorder, liver disorder, myelosuppression, auditory disorder, infection or chickenpox.
  • If you are pregnant, possibly pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, inject this medicine into hepatic artery once a day, followed by a medicine cessation period of at least 4 to 6 weeks. This treatment method should be repeated.
  • The dosing schedule will depend on its medicinal effect. Ask your doctor about the specific dosing schedule.
  • For protection of kidney, water is supplied by intravenous infusion before and after injection of this medicine.
  • For prevention of nausea, antiemetic agent may be administered in advance.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include liver disorder, hepatic dysfunction, loss of appetite, nausea, vomiting, fever, malaise, abdominal pain, rash, hot flush and redness. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • decreased urine output, edema of face and four limbs, headache [acute renal failure]
  • anemia, fever, bleeding tendency  [myelosuppression such as pancytopenia]
  • rapid anemia 1 to 4 days after injection [decreased platelets]
  • rash, facial pallor, edema, respiratory distress [shock, anaphylaxis]
  • loss of appetite, general malaise, nausea, vomiting, and jaundice [fulminant hepatitis, hepatic dysfunction, jaundice]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z